世界中医药
世界中醫藥
세계중의약
WORLD CHINESE MEDICINE
2014年
2期
188-192
,共5页
王秀宝%张季青%陈月玲%陈秋妮%刘秋兰
王秀寶%張季青%陳月玲%陳鞦妮%劉鞦蘭
왕수보%장계청%진월령%진추니%류추란
中药保留灌肠%盆腔炎性疾病%临床综合疗效%中医临床症候的疗效%安全性
中藥保留灌腸%盆腔炎性疾病%臨床綜閤療效%中醫臨床癥候的療效%安全性
중약보류관장%분강염성질병%림상종합료효%중의림상증후적료효%안전성
TCM Clyster%Pelvic inflammation%Clinical overall efficacy%TCM symptoms efficacy%Safety
目的：观察盆炎灌肠方保留灌肠治疗盆腔炎性疾病的临床疗效。方法：将入选的120例患者随机分为4组，每组30例，A组予盆炎灌肠方保留灌肠，B组予口服蒲皂愈炎汤，C组予口服蒲皂愈炎汤并保留灌肠，D组予奥硝唑分散片。结果：经14 d治疗后，A组、B组、C组的中医临床痊愈率、显效率和总有效率均明显优于D组（ P＜0.05或P＜0.01）。 A组与C组的显效率分别为50.00％和53.33％（P＞0.05）；A、C组与B组比较（P＜0.05或P＜0.01）。总有效率依次为C组93.33％、A组90.00％、B组76.67％、D组66.67％，A组与C组比较（P＞0.05）；A、C组与B组比较（P＜0.05或P＜0.01）。表明A组和C组的疗效明显优于B组和D组。4组患者治疗后的局部体征评分、疼痛评分、止痛疗效及中医症状评分均较治疗前明显改善（ P＜0.05或P＜0.01）。止痛疗效A组、B组、C组、D组的总有效率依次为86.67％、76.67％、83.33％和73.33％，A组优于其他3组。 A组有2例、C组有1例于1～3 d时出现肛门口轻微不适感，未经特殊处理自行好转；D组有7例有恶心感，加服维生素B6后改善。表明A组无明显不良反应；治疗费4组从少到多依次为D组2.59×14＝87.63（元）、A组8.41×14＝114.94（元）、B组10.7×14＝149.94（元）、C组的费用（8.41＋10.7）×14＝264.74（元）。结论：盆炎灌肠方保留灌肠治疗盆腔炎性疾病的作用独特、疗效确切、费用低廉。
目的：觀察盆炎灌腸方保留灌腸治療盆腔炎性疾病的臨床療效。方法：將入選的120例患者隨機分為4組，每組30例，A組予盆炎灌腸方保留灌腸，B組予口服蒲皂愈炎湯，C組予口服蒲皂愈炎湯併保留灌腸，D組予奧硝唑分散片。結果：經14 d治療後，A組、B組、C組的中醫臨床痊愈率、顯效率和總有效率均明顯優于D組（ P＜0.05或P＜0.01）。 A組與C組的顯效率分彆為50.00％和53.33％（P＞0.05）；A、C組與B組比較（P＜0.05或P＜0.01）。總有效率依次為C組93.33％、A組90.00％、B組76.67％、D組66.67％，A組與C組比較（P＞0.05）；A、C組與B組比較（P＜0.05或P＜0.01）。錶明A組和C組的療效明顯優于B組和D組。4組患者治療後的跼部體徵評分、疼痛評分、止痛療效及中醫癥狀評分均較治療前明顯改善（ P＜0.05或P＜0.01）。止痛療效A組、B組、C組、D組的總有效率依次為86.67％、76.67％、83.33％和73.33％，A組優于其他3組。 A組有2例、C組有1例于1～3 d時齣現肛門口輕微不適感，未經特殊處理自行好轉；D組有7例有噁心感，加服維生素B6後改善。錶明A組無明顯不良反應；治療費4組從少到多依次為D組2.59×14＝87.63（元）、A組8.41×14＝114.94（元）、B組10.7×14＝149.94（元）、C組的費用（8.41＋10.7）×14＝264.74（元）。結論：盆炎灌腸方保留灌腸治療盆腔炎性疾病的作用獨特、療效確切、費用低廉。
목적：관찰분염관장방보류관장치료분강염성질병적림상료효。방법：장입선적120례환자수궤분위4조，매조30례，A조여분염관장방보류관장，B조여구복포조유염탕，C조여구복포조유염탕병보류관장，D조여오초서분산편。결과：경14 d치료후，A조、B조、C조적중의림상전유솔、현효솔화총유효솔균명현우우D조（ P＜0.05혹P＜0.01）。 A조여C조적현효솔분별위50.00％화53.33％（P＞0.05）；A、C조여B조비교（P＜0.05혹P＜0.01）。총유효솔의차위C조93.33％、A조90.00％、B조76.67％、D조66.67％，A조여C조비교（P＞0.05）；A、C조여B조비교（P＜0.05혹P＜0.01）。표명A조화C조적료효명현우우B조화D조。4조환자치료후적국부체정평분、동통평분、지통료효급중의증상평분균교치료전명현개선（ P＜0.05혹P＜0.01）。지통료효A조、B조、C조、D조적총유효솔의차위86.67％、76.67％、83.33％화73.33％，A조우우기타3조。 A조유2례、C조유1례우1～3 d시출현항문구경미불괄감，미경특수처리자행호전；D조유7례유악심감，가복유생소B6후개선。표명A조무명현불량반응；치료비4조종소도다의차위D조2.59×14＝87.63（원）、A조8.41×14＝114.94（원）、B조10.7×14＝149.94（원）、C조적비용（8.41＋10.7）×14＝264.74（원）。결론：분염관장방보류관장치료분강염성질병적작용독특、료효학절、비용저렴。
Objective:To observe the clinical curative effect of TCM Clyster on pelvic inflammation .Methods:the 120 patients were ran-domized into 4 arms:A, B, C and D, 30 cases in each arm.We gave TCM Clyster to Arm A, Puzao Yuyan Decoction to Arm B, TCM Clyster and Puzao Yuyan Decoction to Arm C , Ornidazole dispersible tablet to Arm D .Results:After treatment for 14 consecutive days , the recovery rate , significant effective rate and total effective rate of Arm A , B and C were significantly higher than that of Arm D ( P<0.05 orP<0.01).The significant effective rate of Arm A and C were 50.00%and 53.33%(P>0.05), having statistical significance compared with Arm B (P<0.05 orP<0.01).The total effective rate of Arm C, A, B and D were respectively 93.33%, 90.00%、, 76.67%and 66.67%.Arm A was not statistically different than Arm C , however both arms were significant than Arm B ( P<0.05 orP<0.01), which indicated that the efficacy of Arm A and C was superior to Arm B and D .After treatment, all the arms improved in terms of local symptoms, pain score, analgesic efficacy and TCM symptom score(P<0.05 orP<0.01).The total effective rate of anal-gesic efficacy of Arm A.B,C and D were respectively 86.67%、76.67%、83.33% and 73.33%.2 patients in Arm A and 1 patient in Arm C felt slight discomfort in the anus at day 1-3, which recovered spontaneously without corrective treatment .7 patients in Arm D felt nauseated, which was relieved after taking vitamin B 6.Patients in Arm A reported no obvious adverse reactions .Costs of treatment:Arm D:￥87.63, Arm A:￥114.94, Arm B:￥ 149.94, Arm C:264.74.Conclusion:TCM Clyster is effective to treat pelvic inflammation , and less expensive compared to other treatments in this research .
